KNApSAcK Metabolite C00002950
Metabolite
KNApSAcK Entry
| id | C00002950 |
|---|---|
| Name | Gambogic acid |
| CAS RN | 2752-65-0 |
| Standard InChI | InChI=1S/C38H44O8/c1-20(2)10-9-15-36(8)16-14-24-29(39)28-30(40)26-18-23-19-27-35(6,7)46-37(33(23)41,17-13-22(5)34(42)43)38(26,27)45-32(28)25(31(24)44-36)12-11-21(3)4/h10-11,13-14,16,18,23,27,39H,9,12,15,17,19H2,1-8H3,(H,42,43)/b22-13-/t23?,27?,36-,37?,38-/m1/s1 |
| Standard InChI (Main Layer) | InChI=1S/C38H44O8/c1-20(2)10-9-15-36(8)16-14-24-29(39)28-30(40)26-18-23-19-27-35(6,7)46-37(33(23)41,17-13-22(5)34(42)43)38(26,27)45-32(28)25(31(24)44-36)12-11-21(3)4/h10-11,13-14,16,18,23,27,39H,9,12,15,17,19H2,1-8H3,(H,42,43) |
Cluster
| Phytochemical cluster | |
|---|---|
| KCF-S cluster | No. 162 |
Link
ChEMBL
| By standard InChI | |
|---|---|
| By standard InChI Main Layer | CHEMBL265955 CHEMBL555017 CHEMBL1477081 |
KEGG
| By LinkDB | C10062 |
|---|
CTD
| By CAS RN | C052659 |
|---|
Species
Summary
Plant class
| class name | count |
|---|---|
| rosids | 2 |
Family
| family name | count |
|---|---|
| Clusiaceae | 2 |
List (2)
* NCBI
| KNApSAcK organism | *ID | *family | *plant class | *kingdom |
|---|---|---|---|---|
| Garcinia hanburyi | 231906 | Clusiaceae | rosids | Viridiplantae |
| Garcinia morella | 58227 | Clusiaceae | rosids | Viridiplantae |
Human Protein / Gene in interaction
30 ChEMBL Protein in interactions
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P25963 | NF-kappa-B inhibitor alpha | Other cytosolic protein | CHEMBL555017 |
CHEMBL1958660
(1)
CHEMBL1958916
(1)
|
1 / 2 |
| P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL555017 CHEMBL1477081 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
CHEMBL2338911 (1) CHEMBL2338912 (1) |
7 / 44 |
| Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Other cytosolic protein | CHEMBL555017 |
CHEMBL2173038
(1)
|
0 / 0 |
| Q16637 | Survival motor neuron protein | Unclassified protein | CHEMBL1477081 |
CHEMBL1613842
(1)
|
4 / 2 |
| P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL555017 |
CHEMBL937563
(1)
|
0 / 0 |
| P04629 | High affinity nerve growth factor receptor | Trk | CHEMBL555017 |
CHEMBL930429
(1)
CHEMBL930433
(1)
|
2 / 4 |
| Q16543 | Hsp90 co-chaperone Cdc37 | Unclassified protein | CHEMBL555017 |
CHEMBL1803506
(1)
|
0 / 0 |
| P54132 | Bloom syndrome protein | Enzyme | CHEMBL1477081 |
CHEMBL1614067
(1)
|
1 / 2 |
| P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1477081 |
CHEMBL1794311
(1)
|
2 / 3 |
| O14920 | Inhibitor of nuclear factor kappa-B kinase subunit beta | Other serine/threonine protein kinase | CHEMBL555017 |
CHEMBL1958917
(1)
|
0 / 0 |
| O15296 | Arachidonate 15-lipoxygenase B | Enzyme | CHEMBL1477081 |
CHEMBL1613800
(1)
|
0 / 0 |
| Q16620 | BDNF/NT-3 growth factors receptor | Trk | CHEMBL555017 |
CHEMBL937561
(1)
|
1 / 1 |
| Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL1477081 |
CHEMBL1738606
(1)
|
0 / 0 |
| P11021 | 78 kDa glucose-regulated protein | Unclassified protein | CHEMBL1477081 |
CHEMBL1963893
(1)
|
0 / 0 |
| O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1477081 |
CHEMBL1794467
(1)
|
0 / 0 |
| Q16548 | Bcl-2-related protein A1 | Unclassified protein | CHEMBL555017 |
CHEMBL2173037
(1)
|
0 / 0 |
| P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL555017 CHEMBL1477081 |
CHEMBL937564
(1)
CHEMBL1614521
(1)
CHEMBL1613808 (1) |
0 / 0 |
| Q00987 | E3 ubiquitin-protein ligase Mdm2 | Other nuclear protein | CHEMBL555017 |
CHEMBL2338906
(1)
CHEMBL2338907
(1)
CHEMBL2338908 (1) CHEMBL2338909 (1) CHEMBL2338910 (1) |
1 / 5 |
| Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1477081 |
CHEMBL1613910
(1)
|
3 / 3 |
| P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | CHEMBL1477081 |
CHEMBL1614038
(1)
|
2 / 2 |
| P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1477081 |
CHEMBL1614240
(1)
|
0 / 0 |
| P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL1477081 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
| P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL1477081 |
CHEMBL1614250
(1)
CHEMBL1614421
(1)
|
4 / 3 |
| Q07817 | Bcl-2-like protein 1 | Other cytosolic protein | CHEMBL555017 |
CHEMBL2173040
(1)
|
0 / 0 |
| P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | CHEMBL555017 |
CHEMBL2173039
(1)
|
0 / 7 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1477081 |
CHEMBL1794536
(1)
|
0 / 0 |
| Q16288 | NT-3 growth factor receptor | Trk | CHEMBL555017 |
CHEMBL937562
(1)
|
0 / 1 |
| B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1477081 |
CHEMBL1613914
(1)
|
0 / 0 |
| P10599 | Thioredoxin | Unclassified protein | CHEMBL555017 |
CHEMBL2212211
(1)
CHEMBL2212212
(1)
CHEMBL2212214 (1) CHEMBL2212216 (3) CHEMBL2212222 (1) CHEMBL2212224 (1) |
0 / 0 |
| Q99757 | Thioredoxin, mitochondrial | Unclassified protein | CHEMBL555017 |
CHEMBL2212210
(1)
CHEMBL2212213
(1)
CHEMBL2212215 (3) CHEMBL2212221 (1) CHEMBL2212223 (1) |
0 / 0 |
CTD interaction (20)
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C052659 | 9131 |
AIFM1
AIF CMTX4 COWCK COXPD6 PDCD8 |
apoptosis-inducing factor, mitochondrion-associated, 1 | gambogic acid affects the localization of AIFM1 protein |
affects localization
|
protein |
19464570
|
| C052659 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | gambogic acid results in decreased activity of AKT1 protein |
decreases activity
|
protein |
19433130
|
| C052659 | 581 |
BAX
BCL2L4 |
BCL2-associated X protein | gambogic acid results in increased expression of BAX mRNA |
increases expression
|
mRNA |
15968715
|
| C052659 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of BCL2 mRNA] |
decreases expression
/ increases reaction |
mRNA |
19084572
|
| C052659 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | gambogic acid affects the expression of BCL2 protein |
affects expression
|
protein |
19433130
|
| C052659 | 596 |
BCL2
Bcl-2 PPP1R50 |
B-cell CLL/lymphoma 2 | gambogic acid results in decreased expression of BCL2 mRNA |
decreases expression
|
mRNA |
15968715
19084572 |
| C052659 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of CASP3 mRNA] |
decreases expression
/ increases reaction |
mRNA |
19084572
|
| C052659 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | gambogic acid results in decreased expression of CASP3 mRNA |
decreases expression
|
mRNA |
19084572
|
| C052659 | 842 |
CASP9
APAF-3 APAF3 ICE-LAP6 MCH6 PPP1R56 |
caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) | gambogic acid results in decreased expression of CASP9 protein alternative form |
decreases expression
|
protein |
19464570
|
| C052659 | 2932 |
GSK3B
|
glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) | gambogic acid results in decreased activity of GSK3B protein |
decreases activity
|
protein |
19433130
|
| C052659 | 8202 |
NCOA3
ACTR AIB-1 AIB1 CAGH16 CTG26 KAT13B RAC3 SRC-3 SRC3 TNRC14 TNRC16 TRAM-1 bHLHe42 pCIP |
nuclear receptor coactivator 3 (EC:2.3.1.48) | gambogic acid results in decreased expression of NCOA3 |
decreases expression
|
19433130
|
|
| C052659 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | Fluorouracil promotes the reaction [gambogic acid results in decreased expression of PARP1 mRNA] |
decreases expression
/ increases reaction |
mRNA |
19084572
|
| C052659 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | Fluorouracil promotes the reaction [gambogic acid results in increased cleavage of PARP1 protein] |
increases cleavage
/ increases reaction |
protein |
19084572
|
| C052659 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | gambogic acid results in decreased expression of PARP1 mRNA |
decreases expression
|
mRNA |
19084572
|
| C052659 | 142 |
PARP1
ADPRT ADPRT_1 ADPRT1 ARTD1 PARP PARP-1 PPOL pADPRT-1 |
poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) | gambogic acid results in increased cleavage of PARP1 protein |
increases cleavage
|
protein |
19084572
19464570 |
| C052659 | 6198 |
RPS6KB1
PS6K S6K S6K-beta-1 S6K1 STK14A p70_S6KA p70(S6K)-alpha p70-S6K p70-alpha |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) | gambogic acid results in decreased activity of RPS6KB1 protein |
decreases activity
|
protein |
19433130
|
| C052659 | 7298 |
TYMS
HST422 TMS TS |
thymidylate synthetase (EC:2.1.1.45) | gambogic acid inhibits the reaction [Fluorouracil results in increased expression of TYMS mRNA] |
decreases reaction
/ increases expression |
mRNA |
19084572
|
| C052659 | 7298 |
TYMS
HST422 TMS TS |
thymidylate synthetase (EC:2.1.1.45) | gambogic acid results in decreased expression of TYMS mRNA |
decreases expression
|
mRNA |
19084572
|
| C052659 | 7372 |
UMPS
OPRT |
uridine monophosphate synthetase (EC:2.4.2.10 4.1.1.23) | Fluorouracil promotes the reaction [gambogic acid results in increased expression of UMPS mRNA] |
increases expression
/ increases reaction |
mRNA |
19084572
|
| C052659 | 7372 |
UMPS
OPRT |
uridine monophosphate synthetase (EC:2.4.2.10 4.1.1.23) | gambogic acid results in increased expression of UMPS mRNA |
increases expression
|
mRNA |
19084572
|
Related Disease
Diseases related to proteins in ChEMBL interactions
OMIM (28)
| OMIM | preferred title | UniProt |
|---|---|---|
| #300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
| #614401 | Accelerated tumor formation, susceptibility to; actfs |
Q00987
|
| #202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
| #614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
| #210900 | Bloom syndrome; blm |
P54132
|
| #119900 | Digital clubbing, isolated congenital |
P15428
|
| #612132 | Ectodermal dysplasia, anhidrotic, with t-cell immunodeficiency, autosomal dominant |
P25963
|
| #133239 | Esophageal cancer |
P04637
|
| #600274 | Frontotemporal dementia; ftd |
P10636
|
| #259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
| #256800 | Insensitivity to pain, congenital, with anhidrosis; cipa |
P04629
|
| #151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
| #211980 | Lung cancer |
P04637
|
| #300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
| #300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
| #607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
| #613886 | Obesity, hyperphagia, and developmental delay |
Q16620
|
| #260500 | Papilloma of choroid plexus; cpp |
P04637
|
| #260540 | Parkinson-dementia syndrome |
P10636
|
| #172700 | Pick disease of brain |
P10636
|
| #253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
| #253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
| #253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
| #271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
| #275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
| #601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
| #188550 | Thyroid carcinoma, papillary |
P04629
|
| #277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG DISEASE (58)
| KEGG | disease name | UniProt |
|---|---|---|
| H00032 | Thyroid cancer |
P04629
(related)
P04637 (related) |
| H00043 | Neuroblastoma |
P04629
(related)
P04629 (marker) Q16288 (related) Q16620 (related) |
| H00265 | Hereditary sensory and autonomic neuropathy (HSAN) |
P04629
(related)
|
| H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
| H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P10415 (related) |
| H00006 | Hairy-cell leukemia |
P04637
(related)
|
| H00008 | Burkitt lymphoma |
P04637
(related)
|
| H00009 | Adult T-cell leukemia |
P04637
(related)
|
| H00010 | Multiple myeloma |
P04637
(related)
|
| H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
| H00014 | Non-small cell lung cancer |
P04637
(related)
|
| H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
| H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
| H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
| H00018 | Gastric cancer |
P04637
(related)
P10415 (related) |
| H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
| H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
| H00022 | Bladder cancer |
P04637
(related)
|
| H00025 | Penile cancer |
P04637
(related)
P04637 (marker) Q00987 (related) |
| H00026 | Endometrial Cancer |
P04637
(related)
|
| H00027 | Ovarian cancer |
P04637
(related)
|
| H00028 | Choriocarcinoma |
P04637
(related)
P10415 (related) Q00987 (related) |
| H00029 | Vulvar cancer |
P04637
(related)
|
| H00031 | Breast cancer |
P04637
(related)
|
| H00033 | Adrenal carcinoma |
P04637
(related)
|
| H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) Q00987 (related) |
| H00038 | Malignant melanoma |
P04637
(related)
|
| H00039 | Basal cell carcinoma |
P04637
(related)
|
| H00040 | Squamous cell carcinoma |
P04637
(related)
|
| H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
| H00042 | Glioma |
P04637
(related)
P04637 (marker) Q00987 (related) |
| H00044 | Cancer of the anal canal |
P04637
(related)
|
| H00046 | Cholangiocarcinoma |
P04637
(related)
|
| H00047 | Gallbladder cancer |
P04637
(related)
|
| H00048 | Hepatocellular carcinoma |
P04637
(related)
|
| H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
| H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
| H01007 | Choroid plexus papilloma |
P04637
(related)
|
| H00021 | Renal cell carcinoma |
P04637
(marker)
|
| H00030 | Cervical cancer |
P10415
(related)
|
| H00054 | Nasopharyngeal cancer |
P10415
(related)
|
| H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
| H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
| H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
| H00342 | Tuberculosis |
P11473
(related)
|
| H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
| H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
| H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
| H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
| H00007 | Hodgkin lymphoma |
P25963
(related)
|
| H00095 | Ectodermal dysplasia associated immunodeficiency (EDA-ID) |
P25963
(related)
|
| H00094 | DNA repair defects |
P54132
(related)
|
| H00296 | Defects in RecQ helicases |
P54132
(related)
|
| H00037 | Alveolar rhabdomyosarcoma |
Q00987
(related)
|
| H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
Q16637 (related) |
| H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
| H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
| H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|